SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 112.22 |
| Enterprise Value ($M) | 108.95 |
| Book Value ($M) | 3.02 |
| Book Value / Share | 0.10 |
| Price / Book | 37.20 |
| NCAV ($M) | 3.02 |
| NCAV / Share | 0.10 |
| Price / NCAV | 37.20 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -6.23 |
| Return on Assets (ROA) | -3.18 |
| Return on Equity (ROE) | -4.84 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.20 |
| Current Ratio | 7.20 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 3.50 |
| Assets | 3.50 |
| Liabilities | 0.49 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -3.94 |
| Net Income | -13.07 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -3.86 |
| Cash from Investing | 0.00 |
| Cash from Financing | 3.86 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,630 | 30,526 | 15.17 | |
| 3,737 | 35,369 | 10.57 | |
| 11,029 | 40,579 | 27.18 | |
| 2,566 | 29,235 | 8.78 | |
| 12,180 | 28,182 | 43.22 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SYBX – Synlogic, Inc. | TCON – TRACON Pharmaceuticals, Inc. |
| TCRT – Alaunos Therapeutics, Inc. | TENX – Tenax Therapeutics, Inc. |
| TFFP – TFF Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io